Impact of MYCN status on response of high-risk neuroblastoma to neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

Impact of MYCN status on response of high-risk neuroblastoma to neoadjuvant chemotherapy

Published:2020-01 Issue:1 Volume:55 Page:130-134
ISSN:0022-3468
Container-title:Journal of Pediatric Surgery
language:en
Short-container-title:Journal of Pediatric Surgery

Author:

Yanishevski David,McCarville M. Beth,Doubrovin Mikhail,Spiegl Hannah R.,Zhao Xiwen,Lu Zhaohua,Federico Sara M.,Furman Wayne L.,Murphy Andrew J.,Davidoff Andrew M.

Funder

St. Jude Children's Research Hospital

Publisher

Elsevier BV

Subject

General Medicine,Pediatrics, Perinatology and Child Health,Surgery

Reference28 articles.

1. Neuroblastoma

2. Molecular basis of clinical heterogeneity in neuroblastoma;Brodeur;Am J Pediatr Hematol Oncol,1992

3. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage;Brodeur;Science,1984

4. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas;Seeger;N Engl J Med,1985

5. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a pediatric oncology group study;Look;J Clin Oncol,1991

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a novel nomogram for predicting overall survival patients with neuroblastoma;European Journal of Surgical Oncology;2024-06

2. Predictive value of 2-deoxy-2-fluorine-18-fluoro-D-glucose positron emission tomography/computed tomography parameters for MYCN amplification in high-risk neuroblastoma;European Journal of Radiology;2024-01

3. Impact of pre-treatment extracellular volume fraction measured by computed tomography on response of primary lesion to preoperative chemotherapy in abdominal neuroblastoma;Clinics;2024-01

4. Differentiated neuroblastoma cells remain epigenetically poised for de-differentiation to an immature state;Disease Models & Mechanisms;2023-12-01

5. Tumor Volume of Onset and MYCN Amplification Predict Poor Prognosis in Patients with Neuroblastoma;2023-06-08